MHRA-licensed alternatives for weight management including semaglutide (Wegovy), liraglutide (Saxenda), orlistat, and tirzepatide (Mounjaro) have well-characterised safety profiles and NICE eligibility criteria
Newer drugs such as tirzepatide (Mounjaro, Zepbound) target GLP1 and GIP (dual agonist)
Safer options include medically supervised GLP-1 therapy, nutritional counseling, cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and holistic approaches like mindfulness-based stress reduction
If youre obese and fit, actually (the) risk of death is half of that of someone (who) is normal weight but unfit
Most insurance companies including Cigna, UnitedHealthcare, Aetna, Blue Cross Blue Shield and Kaiser Permanente cover Wegovy
The best experiences make reentry instant, so you can resume where you left off without reconfiguring preferences or hunting for favorite titles